MA43352B1 - Protéine sans phénylalanine pour le traitement de la phénylcétonurie - Google Patents
Protéine sans phénylalanine pour le traitement de la phénylcétonurieInfo
- Publication number
- MA43352B1 MA43352B1 MA43352A MA43352A MA43352B1 MA 43352 B1 MA43352 B1 MA 43352B1 MA 43352 A MA43352 A MA 43352A MA 43352 A MA43352 A MA 43352A MA 43352 B1 MA43352 B1 MA 43352B1
- Authority
- MA
- Morocco
- Prior art keywords
- protein
- phenylalanine
- food
- phenylketonuria
- treatment
- Prior art date
Links
- 102000004169 proteins and genes Human genes 0.000 title abstract 4
- 108090000623 proteins and genes Proteins 0.000 title abstract 4
- 201000011252 Phenylketonuria Diseases 0.000 title 1
- 235000021245 dietary protein Nutrition 0.000 abstract 3
- 235000018102 proteins Nutrition 0.000 abstract 3
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 abstract 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 abstract 2
- 238000009825 accumulation Methods 0.000 abstract 1
- 230000035508 accumulation Effects 0.000 abstract 1
- 235000007882 dietary composition Nutrition 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 235000013305 food Nutrition 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 244000005700 microbiome Species 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/195—Proteins from microorganisms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/54—Proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Polymers & Plastics (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Soy Sauces And Products Related Thereto (AREA)
- General Preparation And Processing Of Foods (AREA)
Abstract
La présente invention concerne une protéine alimentaire recombinante exempte de phénylalanine et une protéine alimentaire à haute valeur biologique. L'invention concerne en outre un vecteur codant ladite protéine alimentaire, des microorganismes exprimant ladite protéine, un procédé de production de ladite protéine et une composition diététique comprenant ladite protéine destinée à être utilisée comme médicament et / ou aliment à des fins médicales spéciales. Chez les patients présentant des accumulations de phénylalanine dans le corps.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP16186895.5A EP3290436B1 (fr) | 2016-09-01 | 2016-09-01 | Protéine sans phénylalanine pour le traitement de la phénylcétonurie |
Publications (2)
Publication Number | Publication Date |
---|---|
MA43352A MA43352A (fr) | 2018-03-07 |
MA43352B1 true MA43352B1 (fr) | 2019-08-30 |
Family
ID=56883591
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA43352A MA43352B1 (fr) | 2016-09-01 | 2016-09-01 | Protéine sans phénylalanine pour le traitement de la phénylcétonurie |
Country Status (27)
Country | Link |
---|---|
US (1) | US10640538B2 (fr) |
EP (1) | EP3290436B1 (fr) |
JP (1) | JP6954676B2 (fr) |
CN (1) | CN109661401B (fr) |
AU (1) | AU2017317652B2 (fr) |
BR (1) | BR112019004270A2 (fr) |
CA (1) | CA3033271C (fr) |
CY (1) | CY1121886T1 (fr) |
DK (1) | DK3290436T3 (fr) |
ES (1) | ES2742175T3 (fr) |
HR (1) | HRP20191406T1 (fr) |
HU (1) | HUE044665T2 (fr) |
IL (1) | IL265015B2 (fr) |
LT (1) | LT3290436T (fr) |
MA (1) | MA43352B1 (fr) |
MD (1) | MD3290436T2 (fr) |
ME (1) | ME03510B (fr) |
MX (1) | MX2019002422A (fr) |
NZ (1) | NZ750498A (fr) |
PL (1) | PL3290436T3 (fr) |
PT (1) | PT3290436T (fr) |
RU (1) | RU2764796C2 (fr) |
SA (1) | SA519401175B1 (fr) |
SI (1) | SI3290436T1 (fr) |
UA (1) | UA124630C2 (fr) |
WO (1) | WO2018041920A1 (fr) |
ZA (1) | ZA201901505B (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113214363B (zh) * | 2019-09-27 | 2022-12-06 | 湖北康肽药业有限公司 | 一组特殊膳食蛋白质 |
CN110747218A (zh) * | 2019-09-27 | 2020-02-04 | 深圳市诺维健生物技术有限责任公司 | 一种特殊膳食蛋白质的生产方法与应用 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04126051A (ja) * | 1990-09-18 | 1992-04-27 | Snow Brand Milk Prod Co Ltd | フェニルケトン尿症患者用栄養調製物 |
GB9310472D0 (en) | 1993-05-20 | 1993-07-07 | Univ Warwick | Phenylalanine-free protein and dna coding thereof |
GB9314802D0 (en) * | 1993-07-16 | 1993-08-25 | Pharmaceutical Proteins Ltd | Modified proteins |
WO1996017064A1 (fr) | 1994-12-02 | 1996-06-06 | Indiana University Foundation | Proteines sans phenylalanine |
EP1092769B1 (fr) * | 1999-10-15 | 2008-10-29 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Des "tags" polypeptidiques pour la détection et la purification de polypeptides |
DK1339837T3 (da) * | 2000-12-07 | 2008-06-09 | Dsm Ip Assets Bv | Prolyl-endoprotease fra Aspergillus Niger |
US9034402B2 (en) * | 2007-04-16 | 2015-05-19 | Solae, Llc | Protein hydrolysate compositions having improved sensory characteristics and physical properties |
EP2142651B1 (fr) | 2007-04-27 | 2013-05-22 | Pfenex Inc. | Procédé pour rapidement cribler des hôtes microbiens et identifier certaines souches ayant un rendement et/ou une qualité d'expression des protéines hétérologues améliorés |
WO2010124180A1 (fr) * | 2009-04-23 | 2010-10-28 | Phasebio Pharmaceuticals, Inc. | Protéine de fusion de phénylalanine hydroxylase et procédés pour traiter une phénylcétonurie |
WO2013133691A1 (fr) * | 2012-03-09 | 2013-09-12 | N.V. Nutricia | Composition nutritionnelle liquide comprenant des acides aminés libres |
US20150126441A1 (en) | 2012-03-26 | 2015-05-07 | Pronutria, Inc. | Nutritive Fragments and Proteins with Low or No Phenylalanine and Methods |
EP2922416A4 (fr) | 2012-11-20 | 2016-07-20 | Pronutria Inc | Protéines sécrétées modifiées et procédés |
ES2896401T3 (es) | 2014-09-22 | 2022-02-24 | Tanea Medical Ab | Proteínas recombinantes exentas de Phe para su uso en el tratamiento de la fenilcetonuria |
-
2016
- 2016-09-01 MD MDE20180783 patent/MD3290436T2/ro unknown
- 2016-09-01 MA MA43352A patent/MA43352B1/fr unknown
- 2016-09-01 PL PL16186895T patent/PL3290436T3/pl unknown
- 2016-09-01 HU HUE16186895 patent/HUE044665T2/hu unknown
- 2016-09-01 EP EP16186895.5A patent/EP3290436B1/fr active Active
- 2016-09-01 PT PT16186895T patent/PT3290436T/pt unknown
- 2016-09-01 ME MEP-2019-208A patent/ME03510B/fr unknown
- 2016-09-01 LT LTEP16186895.5T patent/LT3290436T/lt unknown
- 2016-09-01 SI SI201630331T patent/SI3290436T1/sl unknown
- 2016-09-01 ES ES16186895T patent/ES2742175T3/es active Active
- 2016-09-01 DK DK16186895.5T patent/DK3290436T3/da active
-
2017
- 2017-08-30 CA CA3033271A patent/CA3033271C/fr active Active
- 2017-08-30 MX MX2019002422A patent/MX2019002422A/es unknown
- 2017-08-30 JP JP2019512755A patent/JP6954676B2/ja active Active
- 2017-08-30 UA UAA201903097A patent/UA124630C2/uk unknown
- 2017-08-30 BR BR112019004270A patent/BR112019004270A2/pt unknown
- 2017-08-30 CN CN201780053903.8A patent/CN109661401B/zh active Active
- 2017-08-30 US US16/329,027 patent/US10640538B2/en active Active
- 2017-08-30 WO PCT/EP2017/071814 patent/WO2018041920A1/fr active Application Filing
- 2017-08-30 IL IL265015A patent/IL265015B2/en unknown
- 2017-08-30 RU RU2019109142A patent/RU2764796C2/ru active
- 2017-08-30 NZ NZ750498A patent/NZ750498A/en unknown
- 2017-08-30 AU AU2017317652A patent/AU2017317652B2/en active Active
-
2019
- 2019-02-24 SA SA519401175A patent/SA519401175B1/ar unknown
- 2019-03-11 ZA ZA2019/01505A patent/ZA201901505B/en unknown
- 2019-08-02 HR HRP20191406 patent/HRP20191406T1/hr unknown
- 2019-08-08 CY CY20191100853T patent/CY1121886T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2019012081A (es) | Proteina de fusion del factor de crecimiento 21 de fibroblastos humanos (hfgf21), metodo de preparacion de la misma y su uso. | |
AU2018240515A1 (en) | Nucleic acids encoding CRISPR-associated proteins and uses thereof | |
MA35507B1 (fr) | Protéines à double fonction pour le traitement de troubles du métabolisme | |
MY173699A (en) | Novel compounds for the treatment of diseases associated with amyloid of amyloid-like proteins | |
WO2012081982A3 (fr) | Composition à base de protéines de lactosérum présentant une astringence réduite | |
MA41067B1 (fr) | Composition comportant de la chitine et des protéines digestibles | |
TR201908777A2 (tr) | Suda Çözünür ve Suda Çözünür Olmayan Özellikte Yüksek Antioksidan Kapasitesine Sahip Propolis Ürünleri ve Üretim Yöntemi | |
MX2021010264A (es) | Formulaciones estables de proteina. | |
WO2017062468A8 (fr) | Agonistes de ppar, composés, compositions pharmaceutiques et méthodes d'utilisation de ceux-ci | |
EA201791537A1 (ru) | Фармацевтическая композиция на основе наночастиц доцетаксела-альбумина, способ ее получения и ее применение | |
MA43352B1 (fr) | Protéine sans phénylalanine pour le traitement de la phénylcétonurie | |
EA201790223A1 (ru) | Водный препарат, содержащий парацетамол и ибупрофен | |
MA45172B1 (fr) | Arn modifié codant pour des polypeptides vegf-a, formulations et utilisations associées | |
WO2020109620A3 (fr) | Souches bactériennes pour utilisations médicales | |
MA43474B1 (fr) | Systèmes de formulation pour glycolipides antimicrobiens | |
MX2019014697A (es) | Proteínas del receptor para productos finales de la glicación avanzada (rage) para el tratamiento de fibrosis y enfermedades mediadas por daño al adn. | |
MX2022001489A (es) | Proceso para la preparacion de una composicion que comprende un polipeptido de proteina d. | |
Yudiansah | Faktor-Faktor yang mempengaruhi Sikap Remaja tentang Perilaku Seks Bebas di SMK Bhakti Kencana Subang Tahun 2020 | |
MA50034B1 (fr) | Composition de stimulation ovarienne contrôlée | |
Sirak et al. | Immunohistochemical features of root end granuloma in chronic periodontitis | |
Mohaghegh et al. | Correction to: isolated human and livestock echinococcus granulosus genotypes using real-time PCR of cox1 gene in northeast Iran | |
Bohonovich et al. | Late manifest forms of syphilis in previously treated patients | |
EP4279080A3 (fr) | Traitement et prophylaxie d'une infection k. pneumoniae | |
JP6333933B1 (ja) | 絹糸腺発酵液 | |
WO2021121444A3 (fr) | Formulation stable et de haute concentration de l'anticorps nimotuzumab |